Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.

by Kate Yandell

COVID-19 slowed or stopped enrollment in some cancer clinical trials.

by Kate Yandell

Data shed light on risk factors for death among people with cancer infected with the coronavirus.

by Kate Yandell

I have brain cancer, and my wife is a health care worker. These are some questions we had to consider leading up to and after her diagnosis with COVID-19.

by Adam Hayden

I was afraid that my thyroid cancer diagnosis would derail my graduate school plans. Instead, it helped shape my career path.

by Carly Flumer

Studies show the benefits palliative care can provide to advanced cancer patients, but also highlight inequities in access.

by Jen Tota McGivney

Researchers from around the globe share insights into the outcomes of people with cancer who are infected with the coronavirus.

by Bradley Jones

At the AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer screening and speed up diagnosis.

by Kate Yandell

Cancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.

by Jon Kelvey

For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.

by Cheryl Platzman Weinstock